Compound Detail

CHEMBL503821

RENIERAMYCIN O

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C/C=C(/C)C(=O)OC[C@H]1C2=C(C[C@H]3[C@H]4C5=C(C(=O)C(C)=C(OC)C5=O)[C@H](O)[C@@H]([C@H](C#N)N13)N4C)C(=O)C(C)=C(OC)C2=O

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL503821
Name	RENIERAMYCIN O
Phase	Preclinical
Structure Type	MOL
InChI Key	GBUWZFVJCKIAMH-TVNZNNQYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

591.6

MW (Da)

0.63

ALogP

HBA

HBD

163.5

PSA (Å²)

0.27

QED

Ro5 Violations

Rot. Bonds

Natural Product First in Class Prodrug

IC50 6 meas. best 7.55

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HCT-116 CHEMBL394	IC50	7.55	7.55	28.0	3
QG-56 CHEMBL612268	IC50	7.4	7.4	40.0	3

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HCT-116	IC50	=	28.0	nM	7.55	Cytotoxicity against human HCT116 cells after 4 days	15217287
HCT-116	IC50	=	28.0	nM	7.55	Cytotoxicity against human HCT116 cells after 4 days	14640515
HCT-116	IC50	=	28.0	nM	7.55	Cytotoxicity against human HCT-116 cells assessed as cell growth inhibition	33333398
QG-56	IC50	=	40.0	nM	7.4	Cytotoxicity against human QG56 cells after 4 days	15217287
QG-56	IC50	=	40.0	nM	7.4	Cytotoxicity against human QG56 cells after 4 days	14640515
QG-56	IC50	=	40.0	nM	7.4	Cytotoxicity against human QG-56 cells assessed as cell growth inhibition	33333398

PubMed	DOI	Target Context	# Activities
15217287	10.1021/np030534o	HCT-116	1
15217287	10.1021/np030534o	QG-56	1
14640515	10.1021/np030262p	HCT-116	1
14640515	10.1021/np030262p	QG-56	1
14640515	10.1021/np030262p	DLD-1	1
14640515	10.1021/np030262p	NCI-H460	1
33333398	10.1016/j.ejmech.2020.113092	HCT-116	1
33333398	10.1016/j.ejmech.2020.113092	QG-56	1

Data from ChEMBL 36 via Core Engine